San Diego – A jury recently awarded Boston Scientific $19.5 million in a patent infringement case over a heart stent. The decision, handed down by the U.S. District Court in Delaware, ruled that Cordis Corp was indeed guilty of patent infringement and owes Boston Scientific $18.5 million for lost profits and $1 million in royalties
